# AIS Decision Tool 2026

> AIS Decision Tool 2026 (iPhone/iPad app by RxBuilds LLC.)

- Source: https://appshunter.io/ios/app/ais-decision-tool-2026/id6760186011 (this page in markdown: same URL + `.md`)
- Developer: [RxBuilds LLC](https://appshunter.io/developer/1882339108)
- Category: Medical, Education
- Price: Free with in-app purchases
- Age rating: 17+
- Requires: iOS 15.1 · 48 MB
- Languages: English
- Released: 2026-04-13
- Data updated: 2026-07-09
- User reviews in markdown: https://appshunter.io/ios/app/ais-decision-tool-2026/id6760186011/reviews.md

## What is AIS Decision Tool 2026?

A rapid clinical decision support tool for physicians and advanced practice providers managing acute ischemic stroke. Built by a board-certified vascular neurologist and neurohospitalist for use at the point of care.

Features:

EVT eligibility assessment across all vessel territories (ICA/M1, M2, Basilar, Pediatric)
IVT (tPA/Tenecteplase) recommendation engine with full contraindication checklist
Extended window assessment using EXTEND penumbra criteria (4.5-9h)
Wake-up and unknown onset protocols (WAKE-UP trial criteria)
ASPECTS integration
Absolute and relative contraindication screening
Integrated management checklist
Dosing reference for alteplase and TNK
Optional AI clinical reasoning assistant — guideline-based answers with Section, Class, and Level of Evidence citations for every response
All core decision support features work fully without AI. The AI assistant is an optional supplement for guideline-based clinical questions.

Based on:
DAWN · DEFUSE-3 · EXTEND · WAKE-UP · and current evidence-based stroke practice

AI Features (Optional):
The AI clinical assistant uses a large language model API to generate guideline-based responses. Do not enter patient names, MRNs, dates of birth, or any PHI. This app is not HIPAA compliant. Model training on user data is disabled. AI responses may contain errors — always verify against institutional protocols.

Intended Users:
Licensed clinicians only — neurologists, emergency physicians, hospitalists, and advanced practice providers involved in acute stroke care.

Disclaimer:
This app is a clinical decision support tool only. It supplements but does not replace clinical judgment, institutional protocols, or direct patient assessment. AI-generated responses are not medical advice. All treatment decisions must be made by a licensed physician based on complete clinical assessment.

## Pricing and in-app purchases

Base price: Free.

**Subscriptions**

| Subscription | Price | Period |
| --- | --- | --- |
| AISdecision tool 2026 | $2.99 | per month |



## Version history (last 2 releases)

### 3 — 2026-05-01

performace improvement and bug fixes

### 1.0 — 2026-04-13

No release notes.

## More apps by RxBuilds LLC

- [RxFinance](https://appshunter.io/ios/app/rxfinance/id6760018360)
- [Neurocalc Pro](https://appshunter.io/ios/app/neurocalc-pro/id6760188030)
- [Brain Zap (31f8b7)](https://appshunter.io/ios/app/brain-zap-31f8b7/id6760255349)
- [LipidIQ](https://appshunter.io/ios/app/lipidiq/id6760669194)
- [TaxRx](https://appshunter.io/ios/app/taxrx/id6761803370)

All apps by RxBuilds LLC: https://appshunter.io/developer/1882339108

## Related topics

[ais decision tool 2026](https://appshunter.io/ios/topics/ais-decision-tool-2026) · [decision tool](https://appshunter.io/ios/topics/decision-tool)

---

*Data collected daily from the US App Store and indexed by [AppsHunter](https://appshunter.io/). User reviews are verbatim App Store reviews. Ratings, prices and chart positions refresh continuously; this snapshot is from 2026-07-09.*